(Q44072585)
Statements
1 reference
High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/microl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients). (English)
1 reference
1 reference
Montserrat Lonca
1 reference
Jose M Gatell
1 reference
EfaVIP Cohort Study Group
1 reference
Jose M Miró
1 reference
María A Costa
1 reference
Juan González
1 reference
Rafael Rubio
1 reference
Jose M Peña
1 reference
Alicia Lorenzo
1 reference
Angel Del Palacio
1 reference
Juan José Vázquez
1 reference
1 July 2002
1 reference
Identifiers
1 reference